Nirav Suresh Daftary

Nirav Suresh Daftary

Active Director Director DIN 00708346
DIN 00708346 First appointment Jun 1992 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 3 historical roles
Total affiliations 8 Since Jun 1992
Shareholding value •••• Premium profile

About Nirav Suresh Daftary

Data last updated:

Nirav Suresh Daftary is a Director at Biomed Healthtech Private Limited (since 1992), Designated Partner at Goldcrest Consultants Llp (since 2018) and Designated Partner at Sankalp Placements India Llp (since 2018), and holds 2 more current directorships. The companies operate in Healthcare, Business Services and Business Outsourcing. The largest current company by reported revenue is Biomed Healthtech Private Limited at ₹2.02 Cr (FY 2024). Earlier, Nirav Suresh Daftary was a Director at Hospicon (India) Private Limited (2004–2018) and Director at Sankalp Placements India Private Limited (2005–2018) and 1 more.

DIN 00708346
Primary Designation Director
Industry Healthcare
First Appointment 30 Jun 1992
Oldest Company Age 37 yrs
Largest company Biomed Healthtech Private Limited · ₹2.02 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biomed Healthtech Private Limited U51507MH1989PTC052161
Director30 Jun 19921989₹2.02 Cr (FY 2024)Active
Designated Partner25 Jan 20182018Active
Designated Partner25 Jan 20182018Active
Designated Partner09 Jan 20182018Active
Designated Partner29 Apr 20152015Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hospicon (India) Private Limited U93000MH2004PTC149308
Director28 Oct 20042004₹18,200 (FY 2017)Converted To Llp
Director07 Oct 20052004₹14.3 Lakh (FY 2017)Converted To Llp
Director22 Nov 20042004₹14,052 (FY 2017)Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Biomed Healthtech Private Limited
Biofusion Healthtech Llp
Hospicon (India) Llp
Goldcrest Consultants Llp
Premium access

Shareholding and investment profile for Nirav Suresh Daftary

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nirav Suresh Daftary

Nirav Suresh Daftary currently holds 5 directorships: Biomed Healthtech Private Limited (Director, since 30 Jun 1992, revenue ₹2.02 Cr (FY 2024)); Goldcrest Consultants Llp (Designated Partner, since 25 Jan 2018); Sankalp Placements India Llp (Designated Partner, since 25 Jan 2018); Hospicon (India) Llp (Designated Partner, since 09 Jan 2018); Biofusion Healthtech Llp (Designated Partner, since 29 Apr 2015).

Nirav Suresh Daftary was first appointed on 30 Jun 1992 as Director at Biomed Healthtech Private Limited. The most recent appointment on record is 25 Jan 2018 at Sankalp Placements India Llp.

Nirav Suresh Daftary held 3 earlier board appointments: Hospicon (India) Private Limited (Director, 28 Oct 2004 to 08 Jan 2018); Sankalp Placements India Private Limited (Director, 07 Oct 2005 to 24 Jan 2018); Goldcrest Consultants Private Limited (Director, 22 Nov 2004 to 24 Jan 2018).

The current boards of Nirav Suresh Daftary's companies include Govindsingh Devsingh Bhandari (Biomed Healthtech Private Limited), Mayuri Mukesh Daftary (Biomed Healthtech Private Limited), Mukesh Shantilal Daftary (Biomed Healthtech Private Limited), Prabhat Kumar Mishra (Biomed Healthtech Private Limited), Alka Nirav Daftary (Goldcrest Consultants Llp), Mihir Praful Shah (Goldcrest Consultants Llp), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available